These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1751 related articles for article (PubMed ID: 16698746)

  • 21. Classification of inflammatory bowel disease.
    Lennard-Jones JE
    Scand J Gastroenterol Suppl; 1989; 170():2-6; discussion 16-9. PubMed ID: 2617184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Towards a novel molecular classification of IBD.
    Vermeire S
    Dig Dis; 2012; 30(4):425-7. PubMed ID: 22796810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Numerical taxonomy and discriminant analysis applied to non-specific colitis.
    Jones JH; Lennard-Jones JE; Morson BC; Chapman M; Sackin MJ; Sneath PH; Spicer CC; Card WI
    Q J Med; 1973 Oct; 42(168):715-32. PubMed ID: 4606853
    [No Abstract]   [Full Text] [Related]  

  • 24. New patients, new lessons, new thinking in inflammatory bowel disease: World Congress of Gastroenterology Symposium, Montreal, Canada, September 2005.
    Jewell DP
    Colorectal Dis; 2006 May; 8 Suppl 1():1-2. PubMed ID: 16594956
    [No Abstract]   [Full Text] [Related]  

  • 25. Changes in inflammatory bowel disease subtype during follow-up and over time in 44,302 patients.
    Everhov ÅH; Sachs MC; Malmborg P; Nordenvall C; Myrelid P; Khalili H; Elmberg M; Ekbom A; Askling J; Jakobsson G; Halfvarson J; Ludvigsson JF; Olén O
    Scand J Gastroenterol; 2019 Jan; 54(1):55-63. PubMed ID: 30700170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inflammatory bowel disease in the elderly.
    Grimm IS; Friedman LS
    Gastroenterol Clin North Am; 1990 Jun; 19(2):361-89. PubMed ID: 2194950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The changing epidemiology of paediatric inflammatory bowel disease.
    Henderson P; Russell RK; Satsangi J; Wilson DC
    Aliment Pharmacol Ther; 2011 Jun; 33(12):1380-1; author reply 1381-2. PubMed ID: 21569065
    [No Abstract]   [Full Text] [Related]  

  • 28. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies.
    Ng SC; Shi HY; Hamidi N; Underwood FE; Tang W; Benchimol EI; Panaccione R; Ghosh S; Wu JCY; Chan FKL; Sung JJY; Kaplan GG
    Lancet; 2017 Dec; 390(10114):2769-2778. PubMed ID: 29050646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The application of Montreal classification in inflammatory bowel disease].
    Yang CH; Chen X; Dai J; Zhang Y; Ran ZH; Xiao SD
    Zhonghua Nei Ke Za Zhi; 2008 Jan; 47(1):7-10. PubMed ID: 18346317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and pathological aspects of inflammatory bowel disease.
    Marteau P
    Nestle Nutr Workshop Ser Clin Perform Programme; 1999; 2():83-92. PubMed ID: 11490630
    [No Abstract]   [Full Text] [Related]  

  • 31. Perianal disease predicts changes in Crohn's disease phenotype-results of a population-based study of inflammatory bowel disease phenotype.
    Tarrant KM; Barclay ML; Frampton CM; Gearry RB
    Am J Gastroenterol; 2008 Dec; 103(12):3082-93. PubMed ID: 19086959
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is ileocaecal Crohn's disease L1 or L3 according to the Montreal classification?
    Peyrin-Biroulet L
    Gut; 2008 Mar; 57(3):427. PubMed ID: 18268062
    [No Abstract]   [Full Text] [Related]  

  • 33. Inflammatory bowel disease activity assessment with biologic markers and 99mTc-WBC scintigraphy: are there different trends in ileitis versus colitis?
    Charron M
    J Nucl Med; 2003 Oct; 44(10):1586-91. PubMed ID: 14530471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The computed tomographic morphology of Crohn's disease and ulcerative colitis].
    Klein HM; Wein B; Adam G; Ruppert D; Günther RW
    Rofo; 1995 Jul; 163(1):9-15. PubMed ID: 7626763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Inflammatory bowel disease: genotype-fenotype relationship].
    Gómez de la Concha E
    An R Acad Nac Med (Madr); 2006; 123(2):307-17; discussion 318-20. PubMed ID: 17310638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serological markers (anti-Saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic antibodies) in inflammatory bowel disease: diagnostic utility and phenotypic correlation.
    Buckland MS; Mylonaki M; Rampton D; Longhurst HJ
    Clin Diagn Lab Immunol; 2005 Nov; 12(11):1328-30. PubMed ID: 16275949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lumping and splitting through thick and thin bowel.
    Morowitz DA
    J Clin Gastroenterol; 1989 Feb; 11(1):8-9. PubMed ID: 2921495
    [No Abstract]   [Full Text] [Related]  

  • 38. The Crohn's Disease-Ulcerative Colitis Clinical Appraisal Update: Emerging Trends in Clinical Practice.
    Sandborn W; Colombel JF; D'Haens G; Ghosh S; Panaccione R; Panés J; Travis S; Peyrin-Biroulet L
    Clin Gastroenterol Hepatol; 2016 Sep; 14(9):e121-2. PubMed ID: 27464592
    [No Abstract]   [Full Text] [Related]  

  • 39. [Morphologic differential diagnosis of chronic, unspecific, ulcerous colitis].
    Gloor F
    Schweiz Med Wochenschr; 1971 May; 101(20):690-7. PubMed ID: 5578395
    [No Abstract]   [Full Text] [Related]  

  • 40. Pediatric inflammatory bowel disease.
    Antonioli DA
    Pediatr Dev Pathol; 2005; 8(1):2-19. PubMed ID: 15717115
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 88.